共 71 条
[1]
Attanasio R(1991)Doxorubicin for acromegaly: a case report J Endocrinol Investig 14 493-497
[2]
Orlandi P(2001)Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly J Clin Endocrinol Metab 86 2779-2786
[3]
Dallabonzana D(2002)Somatostatin analogs in acromegaly J Clin Enocrinol Metab 87 3013-3018
[4]
Lodrini A(1987)Cytostatics for acromegaly. Marked improvement in a patient with an invasive pituitary tumour Acta Endocrinol 116 347-349
[5]
Ferrari M(1996)Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients Metabolism 45 67-71
[6]
Maccagnano E(2013)Antiproliferative, antiinvasive, and proapoptotic activity of folate receptor alpha-targeted liposomal doxorubicin in nonfunctional pituitary adenoma cells Endocrinology 154 1414-1423
[7]
Verde G(2017)Primary pituitary diffuse large B-cell lymphoma with somatotroph hyperplasia and acromegaly: case report J Neurosurg 126 1725-1730
[8]
Cozzi R(2007)Efficacy and safety of CyberKnife radiosurgery for acromegaly Pituitary 10 19-25
[9]
Liuzzi A(2017)Pegvisomant: a growth hormone receptor antagonist used in the treatment of acromegaly Pituitary 20 129-135
[10]
Chiodini PG(undefined)undefined undefined undefined undefined-undefined